| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10915901 | Nuclear Medicine and Biology | 2015 | 8 Pages |
Abstract
The RGD tracer helps us identify the vascular normalization window and it shows a supra-additive effect of bevacizumab when administered two hours before radiotherapy.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Stéphanie Becker, Pierre Bohn, Anne-Charlotte Bouyeure-Petit, Romain Modzelewski, David Gensanne, Jean-Michel Picquenot, Bernard Dubray, Pierre Vera,